Autoimmune hepatitis after SARS C��OV-2 vaccination

Ruiz, Sandra Díez; Castro, Raisa Quiñones; Vega, Laura; Izquierdo, Alia Martín; Puente, Isabel González; Martín, Laura Rodríguez; Rodríguez, Rubén Díez; Plaza, Francisco Jorquera

doi:10.17235/reed.2023.9579/2023

Cited by 1 publication

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In recent years, the global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination campaign has raised concerns about potential adverse events, including the development or exacerbation of auto-immune problems [1][2][3]. Studies showed that the SARS-CoV-2 vaccination is associated with increased risk of immune thrombocytopenic purpura, autoimmune liver diseases, Guillain-Barré syndrome, IgA nephropathy (IgAN), rheumatoid arthritis and systemic lupus erythematosus (SLE) [1,[4][5][6]. Prior to the wide application of SARS-CoV-2 vaccinations, there were seldom reports of vaccine associated glomerular diseases.…”

Section: Introductionmentioning

confidence: 99%

New-Onset of Membranous Lupus Nephritis after COVID-19 Vaccination: aCase Report andLiterature Review

Zhang,

Zhu,

Wan

et al. 2023

J Clin Nephrol Res

View full text Add to dashboard Cite

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is an important method to reduce the spread of Coronavirus disease 2019 (COVID-19). While most recipients experience only mild side effects such as fever, fatigue, and injection site pain, it has been found that SARS-CoV-2 vaccination is associated with a few autoimmune problems, including the development of immune thrombotic thrombocytopenia, autoimmune liver disorders, rheumatoid arthritis, IgA nephropathy (IgAN) and systemic lupus erythematosus (SLE). There have been several reports documenting the occurrence of lupus nephritis (LN) after administration of the SARS-CoV-2 vaccine. Considering the ability to activate the immune system, vaccines carry a series of risk inducing flares or exacerbating disease in patients with glomerulonephritises.

show abstract